logo

Latest news

Sieg et al. 2026

With the new funding period just started, we are excited to share the most recent paper of CRC1530

Abstract: 

Caspase-3 (CASP3) and caspase-7 (CASP7) are the two major executioner caspases that are proteolytically activated by upstream initiator…

CRC 1530 Coffee Break ☕ with Sebastian Scheich

Kristie: Hi Sebastian, could you tell us a bit about yourself and what you're researching right now?

Sebastian: Hello, my name is Sebastian Scheich.…

New publication on overcoming fratricide in CD86-targeted CAR-T cell therapy

Abstract: 

Despite its remarkable success in the treatment of several hematological malignancies, cellular immunotherapy using chimeric antigen…

CRC 1530 Gender Equity Spotlight: From Competence to Confidence - Making Your Expertise Visible

We are pleased to host this special keynote, which takes place as part of the regular meetings of the women physicians in the Department I of Internal…

CRC 1530 Double Feature: Talk by Fleur Peters + Lymphoma Tech Meeting

We are pleased to invite you to an exciting CRC 1530 Double Feature on 16 June.

 

Our next speaker in the CRC 1530 Seminar Series is

 

Fleur S.…

New publication: Pathogenesis of diffuse large B cell lymphoma proteogenotypes

Our team in Frankfurt investigated the clinical and molecular diversity of DLBCL through integrated proteogenomic profiling.

on-site visit

We did it!

Great news for B cell malignancy research! 🎉

Class of 2026

Celebrating our PhD awardees!

🥳 Lets start the weekend with great news

New paper out by project A05

 

CRC 1530 Seminar Series: Dr. Dr. Mirco Friedrich

We are excited to announce our next CRC 1530 seminar featuring Dr. Dr. Mirco J. Friedrich, Principal Investigator at the German Cancer Research Center…